Related Experiment Video
Updated: Jun 19, 2026

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
Pharmacological management of constipation
A V Emmanuel1, J Tack, E M Quigley
1Physiology Unit, University College Hospital, London, UK. a.emmanuel@ucl.ac.uk
This review offers practical guidance on laxative use, integrating knowledge of how they work with scientific evidence. It aims to improve patient care and treatment strategies for constipation.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Constipation is a common gastrointestinal issue requiring effective management.
- Laxatives are frequently used but their appropriate application can be complex.
Purpose of the Study:
- To provide a pragmatic, evidence-based approach to selecting and using laxatives.
- To synthesize current understanding of laxative mechanisms and clinical evidence.
Main Methods:
- Review of scientific literature on laxative mechanisms of action.
- Analysis of clinical trial data and evidence supporting laxative efficacy and safety.
Main Results:
- Different laxative classes possess distinct mechanisms of action.
- Evidence supports the use of specific laxatives for various types of constipation.
Conclusions:
- A practical framework for laxative selection can optimize treatment outcomes.
- Understanding mechanisms and evidence is key to effective constipation management.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Irritable Bowel Syndrome III: Medical and Nursing Management